Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 232

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 6
Chunk 232
---
 of directors has determined that each of David Milch and Ruth Alon is an audit committee financial expert as defined by the
SEC rules and has the requisite financial experience as defined by the listing rules of Nasdaq.

Our board of directors has
determined that each member of our audit committee is “independent”, as such term is defined in Rule 10A-3(b)(1) under the
Exchange Act, which is different from the general test for independence of board and committee members.

Audit committee role

Our board of directors has
adopted an audit committee charter setting forth the responsibilities of the audit committee, which are consistent with the Companies
Law, the SEC rules, and the listing rules of Nasdaq. These responsibilities include:

  appointing, retaining, and overseeing our independent auditors and any other registered public accounting firm engaged for the purpose of preparing or issuing an audit report or related work, s...  

  ensuring that the independent auditor prepares and delivers, at least annually, a written statement delineating all relationships between the independent auditor and Alpha Tau, actively engagin...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  overseeing the accounting and financial reporting processes of our company;  

  reviewing transactions (other than transactions related to compensation or terms of services) between the Company and officers and directors, affiliates of officers or directors, or transaction...  

  recommending to the board of directors the retention and termination of the internal auditor, and the internal auditor’s engagement fees and terms, in accordance with the Companies Law, as well...  

  reviewing with management and our independent auditor our annual and quarterly financial statements prior to publication, filing, or submission to the SEC;  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  discussing Alpha Tau’s earnings press releases, as well as financial information and earnings guidance provided to analysts and rating agencies;  

  setting clear hiring policies for employees or former employees of Alpha Tau’s independent auditor;  

  pre-approving audit and non-audit services to be provided by the independent auditors and related fees and terms;  

  preparing all reports as may be required of an audit committee under the rules and regulations promulgated under the Exchange Act;  
 ──────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  reviewing with our general counsel and/or external counsel